GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AnteoTech Ltd (ASX:ADO) » Definitions » Debt-to-Revenue

AnteoTech (ASX:ADO) Debt-to-Revenue : 1.72 (As of Dec. 2024)


View and export this data going back to 2000. Start your Free Trial

What is AnteoTech Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

AnteoTech's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was A$0.63 Mil. AnteoTech's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was A$1.64 Mil. AnteoTech's annualized Revenue for the quarter that ended in Dec. 2024 was A$1.32 Mil. AnteoTech's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 was 1.72.


AnteoTech Debt-to-Revenue Historical Data

The historical data trend for AnteoTech's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AnteoTech Debt-to-Revenue Chart

AnteoTech Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.45 1.43 1.36 3.57 5.02

AnteoTech Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.92 12.81 1.31 14.27 1.72

Competitive Comparison of AnteoTech's Debt-to-Revenue

For the Biotechnology subindustry, AnteoTech's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AnteoTech's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AnteoTech's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where AnteoTech's Debt-to-Revenue falls into.


;
;

AnteoTech Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

AnteoTech's Debt-to-Revenue for the fiscal year that ended in Jun. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.623 + 1.688) / 0.46
=5.02

AnteoTech's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.628 + 1.639) / 1.32
=1.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Dec. 2024) Revenue data.


AnteoTech Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of AnteoTech's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


AnteoTech Business Description

Traded in Other Exchanges
N/A
Address
4/26 Brandl Street, Eight Mile Plains, Brisbane, QLD, AUS, 4113
AnteoTech Ltd is a biotechnology company engaged in the development of specialty products and services and end-user diagnostic products focused on the Battery and Life Science diagnostics markets. Its key areas are the Energy and Life Science Division. The company is developing four products named AnteoX, Ultranode, AnteoBind NXT, and AnteoBind these products are used in the energy, diagnostic, and medical device markets. The company currently has a single segment which is the development of the AnteoTech IP.

AnteoTech Headlines

No Headlines